Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOCRATES: Ustekinumab for Chronic Antibiotic Refractory Pouchitis
NCT04089345Phase 3Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2020
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ustekinumab in pouchitis, sponsored by UZ Leuven. Started Jun 2020; status: completed.
02
Drugs
ustekinumab
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT04089345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04089345.